FVIII-specific human chimeric antigen receptor T-regulatory cells suppress T- and B-cell responses to FVIII
Author:
Affiliation:
1. Department of Medicine, Uniformed Services University of Health Sciences, Bethesda, MD; and
2. Department of Pediatrics, Molecular Hemostasis and Immunodeficiency, University Hospital Frankfurt, Goethe University, Frankfurt, Germany
Abstract
Publisher
American Society of Hematology
Subject
Cell Biology,Hematology,Immunology,Biochemistry
Link
http://ashpublications.org/blood/article-pdf/129/2/238/1400478/blood727834.pdf
Reference20 articles.
1. The hemophilias--from royal genes to gene therapy;Mannucci;N Engl J Med,2001
2. Rate of inhibitor development in previously untreated hemophilia A patients treated with plasma-derived or recombinant factor VIII concentrates: a systematic review;Iorio;J Thromb Haemost,2010
3. First-in-man clinical results of the treatment of patients with graft versus host disease with human ex vivo expanded CD4+CD25+CD127- T regulatory cells;Trzonkowski;Clin Immunol,2009
4. Infusion of ex vivo expanded T regulatory cells in adults transplanted with umbilical cord blood: safety profile and detection kinetics;Brunstein;Blood,2011
5. Adoptive transfer of umbilical cord blood-derived regulatory T cells and early viral reactivation;Brunstein;Biol Blood Marrow Transplant,2013
Cited by 117 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Role of FoxP3+ Regulatory T Cells in Modulating Immune Responses to Adeno-Associated Virus Gene Therapy;Human Gene Therapy;2024-07-01
2. Chimeric antigen receptor T cell therapy for autoimmune disease;Nature Reviews Immunology;2024-06-03
3. The enchanting canvas of CAR technology: Unveiling its wonders in non-neoplastic diseases;Med;2024-06
4. Induction of FoxP3 Pre-mRNA Alternative Splicing to Enhance the Suppressive Activity of Regulatory T Cells from Amyotrophic Lateral Sclerosis Patients;Biomedicines;2024-05-07
5. Reprogramming T cells as an emerging treatment to slow human age-related decline in health;Frontiers in Medical Technology;2024-04-11
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3